AZD4017 + Placebo + AZD4017 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Raised Intraocular Pressure
Conditions
Raised Intraocular Pressure
Trial Timeline
Dec 1, 2010 → Nov 1, 2012
NCT ID
NCT01173471About AZD4017 + Placebo + AZD4017 + Placebo
AZD4017 + Placebo + AZD4017 + Placebo is a phase 2 stage product being developed by AstraZeneca for Raised Intraocular Pressure. The current trial status is completed. This product is registered under clinical trial identifier NCT01173471. Target conditions include Raised Intraocular Pressure.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01173471 | Phase 2 | Completed |